SCHEMBL6931218

SCHEMBL6931218

CS[C@](N)(CCCNC(N)=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 2/20 0.32
TSHR P16473 1/20 0.32
ODC1 P11926 2/20 0.31
ARG1 P05089 1/20 0.31
KDM4C Q9H3R0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL940519 1.00 PAOX (0.32) PAOXTSHRODC1ARG1KDM4C
SCHEMBL8210559 1.00 PAOX (0.32) PAOXTSHRODC1ARG1KDM4C
SCHEMBL27308470 0.86 PAOX (0.48) PAOXTSHRODC1
SCHEMBL232479 0.83 KDM4C (0.32) TSHRKDM4C
SCHEMBL2762949 0.83 KDM4C (0.32) TSHRKDM4C
SCHEMBL6266884 0.83 KDM4C (0.32) TSHRKDM4C
SCHEMBL18676095 0.81 TSHR (0.33) TSHR
SCHEMBL1504428 0.78 ARG1 (0.50) PAOXTSHRARG1KDM4C
SCHEMBL20978268 0.78 ARG1 (0.50) PAOXTSHRARG1KDM4C
SCHEMBL1455221 0.78 ARG1 (0.50) PAOXTSHRARG1KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6649591-B2 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury MEDINOX, INC. 2003-11-18 US disclosed
US-20030181495-A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor MEDINOX, INC. 2003-09-25 US disclosed
US-6596770-B2 Disulfide derivative of a dithiocarbamate is coadministered with an agent that inactivates (or inhibits the production of)the species that induce the expression of nitric oxide synthase MEDINOX, INC. 2003-07-22 US disclosed
EP-1089723-A4 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR MEDINOX INC (US) 2003-07-16 EP disclosed
US-6589991-B1 Treating diseases associated with nuclear factor kappa B pathway; nitric oxide synthase inhibitors, antiinflammatory agents MEDINOX, INC. 2003-07-08 US disclosed
US-20020151540-A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor MEDINOX, INC. 2002-10-17 US disclosed
US-20020045573-A1 POLYDITHIOCARBAMATE-CONTAINING NON-TARGETING MACROMOLECULES AND THE USE THEREOF FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS LAI CHING-SAN (US) 2002-04-18 US disclosed
US-6316502-B1 ADMINISTERING DISULFIDE DERIVATIVE OF DITHIOCARBAMATE COMPOUND TO BIND TO IRON MEDINOX, INC. 2001-11-13 US disclosed
CN-1315856-A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor MEDINOX INC (US) 2001-10-03 CN disclosed
EP-1089723-A1 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR Medinox, Inc. (US) 2001-04-11 EP disclosed
US-6093743-A FOR IN VIVO REDUCTION OF LEVELS OF NITRIC OXIDE, SUCH AS ARE INDUCED BY A VARIETY OF DISEASE STATES, AND FOR TREATMENT OF INFECTIOUS AND/OR INFLAMMATORY CONDITIONS MEDINOX INC. (US) 2000-07-25 US disclosed
WO-1999066918-A9 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR MEDINOX INC (US) 2000-03-30 WO disclosed
WO-1999066918-A1 THERAPEUTIC METHODS EMPLOYING DISULFIDE DERIVATIVES OF DITHIOCARBAMATES AND COMPOSITIONS USEFUL THEREFOR MEDINOX, INC. (US) 1999-12-29 WO disclosed